Description
Doravirine/islatravir, sold under the brand name Idvynso, is fixed-dose combination medication used for the treatment of HIV/AIDS. It contains, doravirine, a HIV-1 non-nucleoside reverse transcriptase inhibitor; and islatravir, a nucleoside analog reverse transcriptase inhibitor.
IDVYNSO (doravirine and islatravir) tablets, for oral use Initial U.S. Approval: 2026
Get Assistance for IDVYNSO Import
Need urgent access to IDVYNSO? We’re here to help.
- Expert support for documentation & approvals
- Fast-track import coordination
- End-to-end patient assistance
Call Now | Enquire Today | WhatsApp Support Available
Contact Sourcing Facilitation Team
Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com
NEWS / UPDATES
Get Access To IDVYNSO (doravirine and islatravir) In India
In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “IDVYNSO” or Generic Name “doravirine and islatravir” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.
Note: South Delhi Pharma, act as a facilitation partner and do not manufacture, sell, or distribute pharmaceutical products. All facilitation activities are conducted in accordance with applicable Indian pharmaceutical and trade regulations.





